Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-30 Sale | 2026-07-02 7:06 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 5,681 | $70 | $397,670 | 9,756 (Direct) | View |
| 2026-06-16 Sale | 2026-06-18 7:08 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 20,000 | $60.75 | $1,215,056 | 55,073 (Indirect Direct) | View |
| 2026-06-15 Sale | 2026-06-17 7:12 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 5,538 | $60.71 | $336,212 | 15,437 (Direct) | View |
| 2026-05-19 Sale | 2026-05-21 6:26 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 199 | $65.51 | $13,036 | 20,975 (Direct) | View |
| 2026-05-19 Sale | 2026-05-21 6:26 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 444 | $65.51 | $29,086 | 75,073 (Indirect Direct) | View |
| 2026-02-18 Sale | 2026-02-20 7:10 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 180 | $73 | $13,140 | 21,174 (Direct) | View |
| 2026-02-18 Sale | 2026-02-20 7:10 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 423 | $73 | $30,879 | 75,517 (Indirect Direct) | View |
| 2026-01-20 Sale | 2026-01-22 7:31 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 3,867 | $35.67 | $137,936 | 21,354 (Direct) | View |
| 2025-11-25 Sale | 2025-11-25 8:30 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 1,157 | $54.28 | $62,802 | 23,737 (Direct) | View |
| 2025-11-25 Sale | 2025-11-25 8:29 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 630 | $54.28 | $34,196 | 24,985 (Direct) | View |
| 2025-11-25 Sale | 2025-11-25 8:28 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 2,207 | $54.28 | $119,796 | 66,443 (Indirect Direct) | View |
| 2025-09-09 Sale | 2025-09-11 9:01 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 6,666 | $46.69 | $311,214 | 49,370 (Indirect Direct) | View |
| 2025-09-04 Sale | 2025-09-08 8:32 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 1,721 | $33.52 | $57,693 | 17,462 (Direct) | View |
| 2025-09-04 Sale | 2025-09-08 8:31 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 11,832 | $36.42 | $430,959 | 56,036 (Indirect Direct) | View |
| 2025-09-02 Sale | 2025-09-04 9:02 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 485 | $30.1 | $14,599 | 19,183 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 9:01 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 1,500 | $30.16 | $45,240 | 67,868 (Indirect Direct) | View |
| 2025-08-19 Sale | 2025-08-21 9:05 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 725 | $26.59 | $19,278 | 36,334 (Direct) | View |
| 2025-08-19 Sale | 2025-08-21 9:04 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 676 | $26.59 | $17,975 | 41,978 (Direct) | View |
| 2025-08-19 Sale | 2025-08-21 9:03 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 1,573 | $26.59 | $41,826 | 156,034 (Indirect Direct) | View |
| 2025-05-19 Sale | 2025-05-21 8:08 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 10,712 | $0.67 | $7,177 | 305,892 (Direct) | View |
| 2025-05-19 Sale | 2025-05-21 8:07 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 9,996 | $0.67 | $6,697 | 314,296 (Direct) | View |
| 2025-05-19 Sale | 2025-05-21 8:07 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 23,208 | $0.67 | $15,549 | 1,064,103 (Indirect Direct) | View |
| 2025-02-19 Sale | 2025-02-21 6:07 pm | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 10,300 | $1.01 | $10,403 | 316,604 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 6:06 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 11,040 | $1.01 | $11,150 | 324,292 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 6:04 pm | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 23,774 | $1.01 | $24,012 | 1,087,311 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-24 Option Award | 2026-07-24 6:35 pm | N/A 2032-12-12 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 16,500 | $0 | 16,500 (Direct) | View |
| 2026-07-24 Option Award | 2026-07-24 6:34 pm | N/A 2032-12-12 | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 57,200 | $0 | 57,200 (Direct) | View |
| 2025-12-22 Option Award | 2025-12-23 6:01 pm | N/A 2033-12-21 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 31,250 | $0 | 50,221 (Direct) | View |
| 2025-12-22 Option Award | 2025-12-23 6:01 pm | N/A 2033-12-21 | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 108,334 | $0 | 162,607 (Direct) | View |
| 2025-11-21 Option Award | 2025-11-25 8:30 pm | N/A 2028-12-17 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 7,432 | $0 | 23,737 (Direct) | View |
| 2025-11-21 Option Award | 2025-11-25 8:29 pm | N/A 2028-12-17 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 5,303 | $0 | 24,985 (Direct) | View |
| 2025-11-21 Option Award | 2025-11-25 8:28 pm | N/A 2028-12-17 | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 19,280 | $0 | 66,443 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-01 7:52 pm | N/A 2033-09-29 | NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-01 7:51 pm | N/A 2033-09-29 | NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-01 7:51 pm | N/A 2033-09-29 | NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-01 7:50 pm | N/A 2033-09-29 | NEKTAR THERAPEUTICS | NKTR | Brainard Diana Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-01 7:49 pm | N/A 2033-09-29 | NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2025-08-19 Option Award | 2025-08-21 9:05 pm | N/A 2031-12-12 | NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer | 16,666 | $0 | 36,334 (Direct) | View |
| 2025-08-19 Option Award | 2025-08-21 9:04 pm | N/A 2031-12-12 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 21,666 | $0 | 41,978 (Direct) | View |
| 2025-08-19 Option Award | 2025-08-21 9:03 pm | N/A 2031-12-12 | NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO | 86,666 | $0 | 156,034 (Direct) | View |
| 2024-09-18 Ownership | 2025-01-17 8:39 pm | N/A 2032-09-17 | NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-09-18 Ownership | 2025-01-17 8:37 pm | N/A 2032-09-17 | NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-09-18 Ownership | 2025-01-17 8:35 pm | N/A 2032-09-17 | NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-09-18 Ownership | 2025-01-17 8:32 pm | N/A 2032-09-17 | NEKTAR THERAPEUTICS | NKTR | Brainard Diana Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2024-09-18 Ownership | 2025-01-17 8:30 pm | N/A 2032-09-17 | NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director | 120,000 | $0 | 120,000 (Direct) | View |